Managing Bone Health With Bisphosphonate Drugs
Lupus is an autoimmune disease that can affect various parts of the body, including the bones. Individuals with lupus may experience a higher risk of bone loss and broken bones (called fractures( due to inflammation and medication side effects. Bisphosphonate drugs have emerged as important tools in helping bone health for lupus patients. In this article, we’ll explore the role of bisphosphonates in lupus treatment and their benefits.
Understanding Managing Bone Health With Bisphosphonates
What Are Bisphosphonate Drugs?
Doctors commonly prescribe bisphosphonates, a class of medications, to treat conditions with weak bones, such as osteoporosis and bone metastases (cancer that spreads to the bones from other body areas). They work by slowing the body’s process of breaking down old bone (by cells called osteoclasts), known as bone resorption. This allows the cells that produce bone (osteoblasts) to form new, stronger bone.
Osteoporosis, Bisphosphonates and Lupus: Key Considerations
Preserving Bone Density: Why Is This Important?
Lupus patients are at a greater risk of bone loss due to factors like chronic inflammation and the use of drugs, like corticosteroids. Doctors use the term “osteoporosis” to describe bone with a higher risk of breaking due to having less bone density. Lupus patients develop broken bones from osteoporosis much more often than people who do not have lupus. Bisphosphonates are pivotal in preventing bone loss by slowing down the resorption process and making the bones stronger.
Treatment and Administration
You can take bisphosphonates orally or intravenously (IV). Popular oral options include alendronate (Fosamax), ibandronate (Boniva), and risedronate (Actonel). The IV form, zoledronic acid (Reclast), is usually given once a year, while the IV form of ibandronate is given every 3 months.
Most of the oral forms must be taken on an empty stomach in the morning with a full glass of water. No food, drink (other than water), or other drugs can be taken for 30 to 60 minutes after taking them. Even a sip of coffee can reduce their absorption (hence the reason for no food, drink, or drugs). Also, it is important to not lie down for 30 – 60 minutes after taking them. If they go back up into the esophagus, they could irritate the esophagus (the tube that connects the mouth and stomach).
Atelvia, a slowly released form of risedronate, is designed to be taken with breakfast. However, it is still important to not lie down afterward. As of 2023, Atelvia now comes in a generic form, making it cheaper.
Benefits for Lupus Patients
Reduction in Fracture Risk
Lupus patients are more susceptible to fractures due to decreased bone density. Bisphosphonates effectively reduce the risk of fractures by maintaining bone strength and structure.
Balancing Corticosteroid Effects
Corticosteroids (like prednisone and methylprednisolone), often used to manage lupus inflammation, can lead to bone loss. Bisphosphonates counteract this effect by promoting bone formation, thus minimizing the impact of corticosteroid-induced bone weakening.
Empowering Patients with Knowledge About Managing Bone Health
Patients with lupus should collaborate closely with their healthcare providers to determine the suitability of bisphosphonate treatment. Healthcare providers consider factors such as disease severity, risk of fractures, and medication interactions.
Monitoring and Follow-Up
Regular bone density scans and monitoring are crucial to assess the effectiveness of bisphosphonates and make any necessary adjustments to the treatment plan.
Potential Side Effects
Oral bisphosphonates can sometimes cause gastrointestinal irritation. Advisors instruct patients to follow dosing guidelines and to stay upright for at least 30 to 60 minutes after taking the medication.
Osteonecrosis of the Jaw
Although rare, there have been cases of osteonecrosis of the jaw associated with bisphosphonate use. Patients should inform their dentist and oral surgeon before undergoing dental procedures.
Another rare side effect is called atypical femoral fractures. Both of these (atypical fractures and osteonecrosis of the jaw) are usually prevented by using bisphosphonates for a short period of time (3-5 years), then stopping them for a while for what doctors call a “drug holiday.”
Managing Bone Health
Bisphosphonate drugs play a vital role in managing bone health for lupus patients. These medications help preserve bone density, reduce fracture risk, and counteract the effects of corticosteroids on bone weakening. By collaborating with healthcare providers, staying informed about potential side effects, and undergoing regular monitoring, individuals with lupus can effectively navigate the complexities of bone health management. Always consult a medical professional before starting or changing any medication regimen.
For more detailed information on bisphosphonates, go to our other bisphosphonate blog post: https://www.lupusencyclopedia.com/bisphosphonate-drugs-and-lupus/